These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35844887)

  • 21. Evolving Epidemiological Characteristics of COVID-19 in Hong Kong From January to August 2020: Retrospective Study.
    Kwok KO; Wei WI; Huang Y; Kam KM; Chan EYY; Riley S; Chan HHH; Hui DSC; Wong SYS; Yeoh EK
    J Med Internet Res; 2021 Apr; 23(4):e26645. PubMed ID: 33750740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and Control Measures for Imported SARS-CoV-2 Transmission During the Postpandemic Period in Shenzhen, China.
    He X; Gong F; Sun X; Hu G; Lin J
    Disaster Med Public Health Prep; 2022 Mar; 17():e143. PubMed ID: 35241200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.
    Zhang J; Wu S; Xu L
    Biosci Trends; 2020 Jul; 14(3):206-208. PubMed ID: 32321904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study.
    Zhang Z; Bi Q; Fang S; Wei L; Wang X; He J; Wu Y; Liu X; Gao W; Zhang R; Gong W; Su Q; Azman AS; Lessler J; Zou X
    Lancet Microbe; 2021 Feb; 2(2):e79-e87. PubMed ID: 33495759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological characteristics and quarantine assessment of imported international COVID-19 cases, March to December 2020, Chengdu, China.
    Zhang W; Yue Y; Hu M; Du C; Wang C; Tuo X; Jiang X; Fan S; Chen Z; Chen H; Liang X; Luan R
    Sci Rep; 2022 Dec; 12(1):21132. PubMed ID: 36477091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining geographical disparities in the incubation period of the COVID-19 infected cases in Shenzhen and Hefei, China.
    Xiao Z; Guo W; Luo Z; Liao J; Wen F; Lin Y
    Environ Health Prev Med; 2021 Jan; 26(1):10. PubMed ID: 33461491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cluster Transmission of Coronavirus Disease 2019 and the Prevention and Control Measures in the Early Stage of the Epidemic in Xi'an, China, 2020.
    Zhang H; Song S; Chen Z; Bai M; He Z; Fu T; Liu K; Shao Z
    Med Sci Monit; 2021 Jun; 27():e929701. PubMed ID: 34121087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study.
    Zhu W; Zhang M; Pan J; Yao Y; Wang W
    BMC Med; 2021 Dec; 19(1):308. PubMed ID: 34872559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological Characteristics of COVID-19 Resurgence in Areas Initially Under Control.
    Li Y; Yang K; Zha S; Wang L; Chen R
    Front Public Health; 2021; 9():749294. PubMed ID: 34888283
    [No Abstract]   [Full Text] [Related]  

  • 31. Notes from the Field: Effectiveness of Prevention and Control Measures for Imported COVID-19 in Guangming District of Shenzhen.
    Chen X; Wang T; Zhao Y; Wu Y; Qie R; Han M; Huang S; Du H; Yao W; Hu D
    Eval Health Prof; 2021 Mar; 44(1):93-97. PubMed ID: 33203226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
    Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
    Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic reproduction number and predicted trends of coronavirus disease 2019 epidemic in the mainland of China.
    Li Y; Wang LW; Peng ZH; Shen HB
    Infect Dis Poverty; 2020 Jul; 9(1):94. PubMed ID: 32678056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the emergency response strategies and measures on the epidemic of COVID-19 in Shenzhen, China].
    Zou X; Wu YS; Liu XJ; Huang SL; He JF; Zhao J; Wu N; Zhang RL; Mei SJ; Liu PY; Zhang Z; Shi XL; Lyu X; Wei L; Ma QS; Lu JH; Li Y; Feng TJ; Peng CQ; Zhang SX; Xia JJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Aug; 41(8):1225-1230. PubMed ID: 32340094
    [No Abstract]   [Full Text] [Related]  

  • 36. Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.
    Jia HL; Li P; Liu HJ; Zhong JY; Qin PZ; Su WZ; Zheng YF; Li KB; Zeng Q; Li JH; Li LZ; Cao L; Wu JB; Chen YY; Jia LL; Song HB; Zhang QW; Yang G; Jing CX; Bo XC; Zhang ZB; Di B; Xiao CL; Ni M
    J Clin Microbiol; 2021 Jul; 59(8):e0007921. PubMed ID: 33952598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission patterns of COVID-19 in the mainland of China and the efficacy of different control strategies: a data- and model-driven study.
    Zu J; Li ML; Li ZF; Shen MW; Xiao YN; Ji FP
    Infect Dis Poverty; 2020 Jul; 9(1):83. PubMed ID: 32631426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The time-varying transmission dynamics of COVID-19 and synchronous public health interventions in China.
    Xiao J; Hu J; He G; Liu T; Kang M; Rong Z; Lin L; Zhong H; Huang Q; Deng A; Zeng W; Tan X; Zeng S; Zhu Z; Li J; Gong D; Wan D; Chen S; Guo L; Li Y; Li Y; Sun L; Liang W; Song T; He J; Ma W
    Int J Infect Dis; 2021 Feb; 103():617-623. PubMed ID: 33181330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
    Zhang J; Litvinova M; Wang W; Wang Y; Deng X; Chen X; Li M; Zheng W; Yi L; Chen X; Wu Q; Liang Y; Wang X; Yang J; Sun K; Longini IM; Halloran ME; Wu P; Cowling BJ; Merler S; Viboud C; Vespignani A; Ajelli M; Yu H
    Lancet Infect Dis; 2020 Jul; 20(7):793-802. PubMed ID: 32247326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronavirus disease 2019 outbreak in Beijing's Xinfadi Market, China: a modeling study to inform future resurgence response.
    Wang XL; Lin X; Yang P; Wu ZY; Li G; McGoogan JM; Jiao ZT; He XJ; Li SQ; Shi HH; Wang JY; Lai SJ; Huang C; Wang QY
    Infect Dis Poverty; 2021 May; 10(1):62. PubMed ID: 33962683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.